.

Pacira Pharmaceuticals reported $526.21M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acelrx Pharmaceuticals ACRX:US $ 32M 10.81M
Aerie Pharmaceuticals AERI:US $ 311.41M 5.56M
Amerisourcebergen ABC:US $ 39744.53M 334.79M
Astellas Pharma 4503:JP Y 989281M 65927M
Bristol Myers Squibb BMY:US $ 30186M 65M
Cara Therapeutics CARA:US $ 176.17M 24.4M
Coherus Biosciences CHRS:US $ 446.78M 65.66M
Depomed DEPO:US $ 117.39M 7.73M
Endo International Ordinary Shares ENDP:US $ 2199.9M 292.89M
Heron Therapeutics HRTX:US $ 194.21M 28.38M
Horizon Pharma HZNP:US $ 3203.09M 255.36M
Ironwood Pharmaceuticals IRWD:US $ 617.83M 92.28M
JAZZ PHA JAZZ:US $ 2590.83M 89.98M
Lannett LCI:US $ 290.12M 28.59M
Ligand Pharmaceuticals LGND:US $ 243.78M 32.28M
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Omeros OMER:US $ 192.72M 17.5M
Pacira Pharmaceuticals PCRX:US $ 526.21M 140.81M
Perrigo Ordinary Shares PRGO:US $ 2651.5M 1284M
Revance Therapeutics RVNC:US $ 260.94M 24.38M
Supernus Pharmaceuticals SUPN:US $ 625.12M 56.6M
Teva Pharmaceutical TEVA:IT 12.16B 287M
Xeris Pharmaceuticals Inc XERS:US $ 161.21M 16.34M
Xoma XOMA:US $ 87.26M 2.35M
Zoetis ZTS:US $ 6651M 186M